Abstract Submission Guidelines


Closing date for submissions HAS NOW BEEN EXTENDED TO: November 7th, 2017 5:00pm

The online submission form can be found HERE. Please review the following ICHAMS 2018 abstract submission guidelines prior to starting the form.



All abstracts accepted for ICHAMS 2018 will be published in the official Conference Abstract Book. Abstracts can be published online with BioMed Central (BMC) Proceedings, if the delegate signs the appropriate waiver at registration during the conference.



  • The lead author (i.e., the individual submitting the abstract and presenting at the conference, if the abstract is selected) has the authority to submit the abstract and has obtained permission from their supervisor (i.e., the corresponding author) and all other authors.
  • The work described in the abstract must meet acceptable ethical standards. When appropriate, please make a statement about the ethical approval required/taken for any clinical and/or animal experiments mentioned in your abstract.
  • Upon abstract submission, the lead author and co-authors agree to all copyright transfer terms.
  • To have your abstract published in the BMC Proceedings, you must sign a waiver at registration (on the day of the conference) stating that:
  1. a) You wish to have your abstract published by ICHAMS 2018,
  2. b) The research is original and has not been published elsewhere (i.e. in any other conference and/or publication) in any form, and
  3. c) All listed authors have agreed to the submission of this abstract (without exception).

Please note: plagiarism will be checked and will not be tolerated.

  • There is no limit to the number of abstracts that an individual may submit. However, you must register and pay the €50 abstract submission fee for each abstract that you submit.
  • The registration fee of €50 must be paid at the time of submission via Stripe and is non-refundable. If your abstract is rejected by the judging committee or if you choose not to present your abstract at the conference, you will not receive a refund. You may still, however, attend all conference events as a passive participant at no additional cost.
    • The lead author can request abstract withdrawal by emailing ichamscommittee@rcsi.ie with the subject “Abstract Withdrawal”. Please include the name of the lead author and title of the abstract exactly as they were written on the abstract submission form. If you withdraw your abstract, you may still attend the conference as a passive participant at no additional cost.
  • Primary responsibility for compliance with any disclosure or nondisclosure requirements resides solely with researchers.



All abstracts must be submitted via the submission form, found here.

  • All submissions MUST be in English.
  • Only original research will be accepted (case reports and literature reviews are not acceptable).
  • Research must have been completed during an undergraduate degree or as part of a professional degree including medicine, pharmacy, and physiotherapy. Research completed as part of a Masters degree or PhD will not be accepted.

When submitting, please assign your abstract to a category below that best suits your research topic.

Abstract Categories

  • Cardiology/Respirology
  • Gastroenterology/Endocrinology
  • Haematology/Immunology/Infectious Disease
  • Musculoskeletal/Orthopaedics/Dermatology/Physiotherapy
  • Nephrology/Urology
  • Neurology/Psychiatry
  • Obstetrics/Gynaecology/Paediatrics
  • Oncology/Pharmacology
  • Ophthalmology/Otolaryngology
  • Public Health/Epidemiology
  • Surgery/Anaesthesiology

A lead author must be assigned for each abstract submission.

  • This individual is the first author listed in the submission and has the primary responsibility for communications with ICHAMS.
  • This individual is responsible for ensuring that all co-authors and company sponsors approve the submission, publication, and potential presentation.
  • This individual will give the oral or poster presentation, if the abstract is selected. The lead author should feel comfortable presenting and answering questions in English.


A corresponding author must also be assigned for each abstract submission.

  • This individual is often the final author listed in the submission and is the most senior author or research supervisor.
  • This individual will be listed as the corresponding author in the BMC proceedings abstract publication (provided that the lead author requests the abstract publication and signs the appropriate waiver on the day of the conference).
  • This individual is ultimately responsible for the quality of work, including any plagiarism concerns.
  • ICHAMS reserves the right to contact the corresponding author, should any concerns about the quality of work be raised.


An abstract submission may contain a maximum of 250 words, including: Introduction, Methods, Results, and Discussion (title and author details not included in word count).

Title: Titles must be concise, functional, and informative, but need not be dull. Use simple language. The title should be a brief description of your research work and it should contain the necessary information to make classification of the article possible. The title may contain a maximum of 150 characters.

Authors: For every submission, there must be a designated lead author (i.e. the individual submitting the abstract), co-authors (i.e. all authors that contributed to the work), and a corresponding author (i.e. your supervisor or most senior author). You must provide all of the following details for EACH author:

  • Full names (first name, last name, middle initial if required);
  • Institutional affiliation (department (i.e. Department of Surgery), institution (i.e. University name), city/town, and country)


If the abstract is being presented on behalf of a study group or is affiliated with an organization that patronizes the investigation, this should appear in a separate Acknowledgements section.

The abstract must be divided into the following subheadings:

  1. Provide a concise background of your research topic, a review of what has already been done in this field and what remains to be known. Outline how your work fills the gap in knowledge in this field. It is recommended to state your research question or aim of the study as the final sentence, to give a clear idea to the reviewers. Use key terms that will re-appear in the answer to the question in your conclusion.
  2. The study design, setting, sample size, selection process of cohorts (if applicable), a description of the intervention (if applicable), and the use of statistics should be described. Please note, the description should be sufficient enough to allow the reviewers to judge the validity of the work.
  3. You may begin with a description of the subjects in the study. Outline the outcomes. Remember, the Results section is an objective list of your findings, and the interpretation/analysis should be included in the Discussion section.
  4. Reiterate the aim of your study, as well as its significance. Provide a clear interpretation of your findings and if appropriate, draw comparisons between subgroups within your study (e.g. treated vs. untreated, male vs. female). Clearly state the answer to your research question. If applicable, state the confounding factors. It is of great importance to state the implications of your study and the future directions that this project can be steered into. Do not use words like ‘we intend to study’ or ‘work will be done to prove’, etc.
  • DO NOT include references, tables, or figures in your abstract submission.
  • General note: Avoid using medical jargon and/or abbreviations excessively. If used, make sure to spell out the abbreviations the first time you mention them.


All abstract submissions are reviewed by our Judging Committee. The abstract review process is anonymous. The top abstracts will be selected for oral presentations, while the remainder will be awarded poster presentations. If you are not awarded an oral or a poster presentation, you may still attend all conference events as a passive participant (at no additional charge). Notifications of acceptance to ICHAMS 2018 will be sent out at least 45 days in advance of the conference.

It is the responsibility of the lead author to share the notifications with their co-authors.

The presenting authors of abstracts accepted for oral or poster presentations must confirm attendance at the conference and make their own housing arrangements.

At this time there are no bursaries or scholarships available from ICHAMS for conference attendance.



Please note that once your abstract is submitted, no additional changes can be made at any time. If you need to make changes you will have to withdraw your abstract and enter a new submission. You can do this up until the submission deadline.

For any additional questions regarding ICHAMS 2018, please visit our FAQ page.